Androgens mediate a number of processes in mammalian and teleost ovaries in a follicle-stage dependent manner, including follicle growth, survival, and apoptosis. We recently reported that the membrane androgen receptor ZIP9 mediates apoptosis in Atlantic croaker granulosa/theca (G/T) cells from mature ovarian follicles, but the effects of androgens on early stage G/T cells in this model remains unknown. Here we show that testosterone mediates pro-and anti-apoptotic responses in a follicle stage-dependent manner in croaker ovarian follicle cells. Testosterone treatment decreased the incidence of apoptosis in G/T cells from early stage follicles (diameter <300 μm) but increased apoptosis in G/T cells from late stage follicles (diameter >400 μm). Small interfering RNA targeting ZIP9, but not the nuclear androgen receptor, blocked the anti-apoptotic response, indicating ZIP9 mediates anti-apoptotic in addition to pro-apoptotic responses. Testosterone treatment of early stage G/T cells resulted in opposite signaling outcomes from those previously characterized for the ZIP9-mediated apoptotic response including decreased cAMP and intracellular free zinc levels, and downregulation of pro-apoptotic member mRNA expression. While ZIP9-mediated apoptosis involves activation of a stimulatory G protein (G s ), activators of G s signaling antagonized the anti-apoptotic response. Proximity ligation and G protein activation assays indicated that in G/T cells from early stage follicles ZIP9 is in close proximity and activates an inhibitory G protein, while in G/T cells from late stage follicles ZIP9 is in close proximity and activates G s . This study demonstrates that ZIP9 mediates opposite survival responses of croaker G/T cells by activating different G proteins in a follicle stage-dependent manner.
Introduction
In the mammalian ovary, androgens are involved in a number of physiological processes such as follicle growth, proliferation, apoptosis, and atresia. These processes are typically exhibited at specific stages of folliculogenesis with androgens promoting growth, proliferation, and survival in early stage follicles, while apoptosis and atresia have been reported at various stages of development [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . While these processes have been better characterized in mammalian models, a limited number of studies have shown that androgens promote follicle growth of previtellogenic follicles in a number of teleosts including short-finned eel, Atlantic cod, and coho salmon [11] [12] [13] . Together these studies suggest that androgen promotion of early follicle growth may be a shared response in mammals and teleosts [12] . In mammals, early in vivo studies indicated that androgen-induced apoptosis and atresia occurs in both preantral [4, 8, 9] and antral [4, 7, 8] murine follicles. However, more recent in vitro studies in porcine and murine models have indicated that the androgen-induced apoptotic response is primarily exhibited by antral follicle cells [5, 6] . Recently, testosterone was found to induce apoptosis of co-cultured granulosa/theca (G/T) cells from reproductively mature Atlantic croaker ovaries with a high proportion of late stage vitellogenic follicles [14, 15] . This suggests that androgen-induced apoptosis in late stage follicles may also be a shared response between teleosts and mammals.
While androgens have been observed to promote a number of physiological responses in mammalian and teleost ovaries, a direct role of the nuclear androgen receptor (AR) in many of these responses remains unclear. The physiological relevance of androgen actions in the ovary that are mediated by the AR has been demonstrated in a number of murine AR knockout (ARKO) models. ARKOs are subfertile, showing reduced litter sizes, defective cumulus-oocyte complex formation, decreased oocyte viability, and increased numbers of atretic and apoptotic follicles [16] [17] [18] [19] . However, ARKO models have not been widely used to verify the loss of function of many androgen responses previously reported in in vitro and in vivo study systems. An additional confounding factor in determining androgen mechanisms of action in the ovary lies in the recent discovery of the novel membrane androgen receptor ZIP9, and the finding that it mediates the androgen-induced apoptotic response observed in Atlantic croaker G/T cells [14] . The zinc transport protein ZIP9 (SLC39A9) was recently cloned and characterized in Atlantic croaker ovaries and found to mediate apoptosis of croaker G/T cells independently of the AR [14] . ZIP9 possesses characteristics of a membrane androgen receptor distinct from the AR, including the presence of a high-affinity and limited capacity binding site specific for androgen hormones but not for synthetic AR antagonists and agonists such as mibolerone [14] . ZIP9 expression is regulated by steroid hormones, and the receptor activates rapid secondary messenger cascades to induce physiological responses [14] . ZIP9 is expressed in both reproductive and non-reproductive tissues in mammals and fish, but information is currently lacking on the receptor's role in mediating androgen actions in the majority of these tissues. To date, ZIP9 has been found to be involved in androgen-induced apoptosis in a number of human cancer cell lines and croaker G/T cells, tight junction formation in murine Sertoli cells, and migration in glioblastoma and prostate cancer cell lines [20] [21] [22] [23] [24] .
ZIP9 is the only known zinc transporter belonging to the ZIP (SLC39A) family that also functions as a steroid receptor. Interestingly, the zinc transport and androgen receptor characteristics of ZIP9 appear to be tightly associated in that androgens mediate intracellular free zinc concentrations though ZIP9 activation [14, 20] . In addition, the ZIP9-mediated increase in intracellular free zinc is essential for the apoptotic response in both croaker G/T cells and human cancer cell lines, the regulation of which is known to involve G protein activation in PC-3 prostate cancer cells overexpressing ZIP9 [14, 25] . While ZIP9-mediated apoptosis involves intracellular zinc regulation, the role of ZIP9's zinc transporter activity in other physiological responses the receptor mediates remains unclear.
Membrane receptors specific for progestins and estrogens have been extensively studied over the last 15 years, since the discovery of the membrane progestin receptor α (mPRα) and G protein-coupled estrogen receptor 1 (GPER), formerly known as GPR30, in 2003 and 2005, respectively [26] [27] [28] . It is well established that these receptors mediate physiological responses by coupling to and activating G proteins, similar to that observed with receptors for peptide hormones in the G protein-coupled receptor (GPCR) superfamily. The membrane estrogen receptor GPER couples to stimulatory G proteins (G s ) in most models [27, 29, 30] , although a number of studies have demonstrated that GPER can mediate pertussis toxinsensitive events [31, 32] , suggesting that the receptor may also activate inhibitory G proteins (G i ). Membrane progestin receptors are primarily known to couple to inhibitory G proteins [26, [33] [34] [35] , although coupling of mPRα to an olfactory G (G olf ) protein has been reported in teleost sperm [36] . ZIP9 has been found to activate different G proteins in diverse cell models, including G s in croaker G/T cells, a G i in human breast and prostate cancer cell lines, and a G q in the spermatogenic cell line GC-2 [14, 20, 37] . However, it remains unclear if this differential coupling of ZIP9 to G proteins is determined by species or cell type differences, or by another mechanism.
We previously reported that ZIP9 mediates androgen-induced apoptosis in G/T cells from reproductively mature Atlantic croaker through a nonclassical signaling pathway [14, 15] . While the ovaries of these fish at reproductive maturity contain a high proportion of late vitellogenic (LV) follicles, the follicle stage specificity of the androgen-induced apoptotic response has not been examined to date. Furthermore, it is unclear if testosterone can also act in an anti-apoptotic fashion in this model, similar to the observations in mammalian and other teleost models [1, 6, 13] . Therefore, the goal of the current study was to characterize androgen actions in croaker G/T cells from early and late stage ovarian follicles, <300 μm and >400 μm in diameter, respectively. These two size classes are typical of early stage follicles that are pre-or early vitellogenic, and late stage follicles that have completed vitellogenesis and are competent to undergo final oocyte maturation. We tested the hypothesis that testosterone induces and inhibits apoptosis in a follicle-stage dependent manner, and further investigated the role of ZIP9 in both responses. Relative expression of ZIP9, as well as membrane androgen binding, was examined in G/T cells from early and late follicle stages. Next, we investigated the role of members of the known ZIP9-mediated apoptotic pathway [15] in the anti-apoptotic response. Finally, we examined potential mechanisms of ZIP9 action between the apoptotic and anti-apoptotic models by exploring the interactions of ZIP9 with inhibitory and stimulatory G proteins as well as testosterone activation of these G proteins.
Materials and methods

Chemicals and materials
Chemicals were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise stated. Testosterone and 4-estren-7α,17α-dimethyl-17β-ol-3-one (Mibolerone) were purchased from Steraloids (Newport, RI Primary granulosa/theca cell culture
Croaker ovarian follicles were separated by repeated pipetting and were passed through 400 μm and 300 μm sieves to obtain two size classes (<300 μm-early stage and >400 μm-late stage) for experimentation. In addition, follicles were passed through 400 μm, 300 μm, and 100 μm sieves to obtain three size classes <100 μm, 100-300 μm, and >400 μm for further examination of stage-dependent anti-apoptotic responses to testosterone (Supplemental Figure S1 ). Extensive washes were performed to remove the undersized follicles from each sieve, however due to the fragility and pliability of the follicles contamination of both smaller follicles in larger follicle classes as well as the presence of larger follicles in smaller follicle classes could not be completely avoided. After the follicles had been separated by size class, G/T cells were isolated by enzymatic digestion with collagenase as previously described [38] . Granulosa/theca 
Follicle size and stage determination
A small subset of follicles from each size class pool were examined and imaged under bright field microscopy (4X). Images were used to characterize 120-200 follicles from each pool as perinuclear stage (PNS, <100 μm), early vitellogenic (EV, 100-300 μm), or LV >300 μm). Characterization was performed on follicles from 3 individual separations.
Culture media estradiol measurements
Granulosa/theca cells from both early and late stage follicles were plated in 24-well plates, grown overnight, and then serum starved for 24 h prior to treatment with vehicle, testosterone (20 nM) or estradiol (E2, 2 nM) for 24 h in the presence of the aromatase inhibitor DL-Aminoglutethimide (100 μM). After the treatment, 0.5 ml of culture media was removed and stored at −80 • C until analyzed. Estradiol was measured using an estradiol ELISA kit (Cayman Chemical) following the manufacturer's protocol.
Membrane protein preparation
All steps were carried out at 4
• C. Ovarian tissue or G/T cells were homogenized in ice-cold HAED buffer (25 mM HEPES, 10 mM NaCl, 1 mM EDTA, 1 mM DTT, pH 7.6) containing protease inhibitor (1μL/mL), followed by centrifugation at 1000 × g for 7 min to pellet the nuclear fraction. The supernatant containing the membrane protein fraction was removed and centrifuged at 20 000 × g for 20 min to pellet membrane proteins. For Western blot analyses the resulting pellet was resuspended in HAED, followed by the addition of 5X reducing sample buffer (Thermo Fisher Scientific, Waltham, MA), boiling for 10 min, and subsequent storage at −80 • C. For the membrane androgen receptor binding assay, the pellet was resuspended in HAED buffer with protease inhibitor. For [ 35 S]GTPγ S binding and precipitation assays the membrane protein pellet was resuspended in GTPγ S binding buffer (100mM NaCl, 5 mM MgCl 2 , 1 mM CaCl 2 , 0.6 mM EDTA, 0.1% BSA, 50 mM Tris-HCl, pH 7.6) with protease inhibitor.
Quantitative real-time PCR analysis
Total mRNA was isolated using Tri Reagent (Sigma-Aldrich) following the manufacturer's protocol. For expression of ZIP9 in G/T cells from different stage follicles, G/T cells were lysed in Tri Reagent immediately after isolation. For examining the effects of testosterone on the expression of the pro-apoptotic genes, G/T cells were starved for 16-24 h prior to a 24 h testosterone treatment, after which mRNA isolation and analysis were performed. Quantitative real-time polymerase chain reaction (qPCR) primers were designed against the mRNA sequences of zip9, bax, and p53 (Supplemental Table 1 ). Quantitative PCR was performed using Verso 1-step RTqPCR SYBR Green Low ROX kit (Thermo Scientific), with 100 ng of mRNA per 15 μL reaction, following the manufacturer's protocol. The qPCR program was set to 50 Samples were run in duplicate and expression of target genes was normalized to the housekeeping gene 18S.
Western blot analysis
Electrophoresis was performed on membrane protein samples loaded on a 10% SDS-PAGE gel. Protein samples were transferred to a nitrocellulose membrane and blocked with 5% nonfat milk for 1 h. After blocking, the membrane was incubated with primary antibodies for ZIP9 1:5000, actin 1:2000 (AnaSpec, Fremont CA), G s 1:1000 (Proteintech, Rosemont, IL), or G i(1/2) 1:1000 (Abcam, Cambridge, MA) overnight at 4
• C. The croaker ZIP9 primary antibody was generated in mice against a partially-purified ovarian membrane fraction with androgen receptor activity and validated for measurement in this species as previously described [14] . Detailed descriptions of antibodies used are presented in Supplemental Table 2 . After incubation, the membranes were washed three times with phosphatebuffered saline (PBS) (NaCl 137 mM, KCl, 2.7 mM, Na 2 HPO 4 10mM, KH 2 PO 4 1.8 mM) followed by incubation with secondary antibodies (1:15 000; LI-COR IREDYE anti-rabbit 800CW, LI-COR IREDYE anti-mouse 680RD; LI-COR, Lincoln, NE) for 1 h at room temperature. Protein bands were visualized using Odyssey infrared imaging system (LI-COR).
Androgen receptor binding competition assay
The ability of steroid competitors to displace [ 3 H]T binding to the membrane fractions of ovarian follicles in single-point competitive binding assays was assessed using methods described previously [39] . Membrane protein (0.5-1.25 mg/ml final) was added to 3 nM (final) 
Apoptosis analyses
Croaker G/T cells grown on round glass coverslips were serumstarved for 16-24 h prior to the addition of steroid and/or drug treatment for 24 h. All treatments were performed in duplicate or triplicate. For Hoechst staining, once treatment was complete the cells were fixed in 4% paraformaldehyde for 20 min at room temperature, stained with 1μg/ml Hoechst 33 342 for 2-3 min, rinsed with PBS, and mounted face down on microscope slides. Apoptotic nuclei were identified based on the morphology of chromatin under epifluorescent microscopy, and apoptotic cells percentage was determined by examination of 400 cells from each slide. For TUNEL staining, cells were fixed and stained following the manufacturer's protocol (In Situ Cell Death Detection Kit; Roche, Indianapolis, IN). Apoptosis was assessed as fluorescent staining of the nuclei and apoptotic cells percentage was determined by examination of 800-1200 cells total from a minimum of four frames of view (10×) for each slide.
Intracellular zinc assay
Granulosa/theca cells were grown in 96-well plates for 1-2 days until confluent. Cells were serum starved for 30 min followed by steroid treatment (20 
Cyclic AMP assay
Cyclic AMP was measured in cell lysates using a cAMP EIA kit (Cayman Chemicals). After isolation, G/T cells were cultured overnight, followed by serum starvation for 72 h. Cells were treated for 10 min with vehicle, testosterone, mibolerone, or TBSA, washed twice with ice-cold PBS, lysed by 20 min incubation with 100 μL 0.1 M HCl on ice, then scraped and repeatedly pipetted (20×) to homogenize the suspension. The suspension was centrifuged at 1000 × g for 10 min, and the supernatant was diluted 2× and assayed immediately. Treatments were conducted in triplicate and data is expressed as relative cAMP concentrations.
Proximity ligation assay
Interaction of ZIP9 with inhibitory and stimulatory G proteins was assessed in situ using a proximity ligation assay (PLA) following the manufacturer's protocol (Duolink; Sigma Aldrich). Granulosa/theca cells grown on coverslips for 1-2 days were fixed, blocked, and incubated with primary antibodies for ZIP9 (mouse 1:200, characterized in [14] ), and G s (rabbit 1:100, Proteintech) or G i(1/2) (rabbit 1:100, Abcam) overnight at 4
• C, before continuing the manufacturer's ligation protocol. For co-staining apoptotic cells, G/T cells were treated, fixed, and stained as in the TUNEL assay prior to blocking and incubation with primary antibodies for the PLA assay. Stained cells were imaged under oil-immersion fluorescence microscopy (100×). Representative images were chosen for the presentation of results.
G protein activation assays
G protein activation was assessed by measuring [ 35 S]GTPγ S binding to G/T cell plasma membranes after incubation with 100 nM testosterone or the same volume of vehicle (1 μl/100 μl) for 20 min at room temperature, using excess GTP to stop the reaction, as described previously [27] . Membrane-bound [ 35 S]GTPγ S was immunoprecipitated with specific antibodies for inhibitory (1:100, G i(1/2) , Abcam) and stimulatory (1:100, G s , Proteintech) G proteins or rabbit IgG (1:100; R&D Systems, Minneapolis, MN) using protein A/G Plusagarose beads (Santa Cruz Biotechnology, Inc., Dallas, TX).
Statistical analysis
All experiments were repeated with G/T cells from a minimum of three fish. In experiments that examined both early and late stage G/T cells, the two subsets were isolated from the same fish. 
Results
Characterization of ZIP9 in different size follicles
The composition of the early and late stage follicle pools was determined by characterizing a subset of follicles from each pool. The early stage size class was primarily made up of 75% PNS and 15% EV follicles, with approximately 10% LV follicles ( Figure 1A ). The late stage size class consisted of primarily LV follicles (74%), with EV and PNS follicles making up 7% and 19%, respectively. The average follicle diameter of PNS, EV, and LV follicles in each pool is shown in Figure 1B . Further separation of the early size class into <100 μm (PNS) and 100-300 μm (EV) size classes resulted in the <100 μm size class consisting of 87% PNS and 13% EV follicles, while the 100-300 μm class was dominated by EV follicles (56%) with 37% PNS and 7% LV follicles present (Supplemental Figure  S1A ). ZIP9 mRNA ( Figure 1C ) and protein ( Figure 1D ) levels were significantly higher in G/T cells from early stage follicles compared to late stage follicles. Figure  1E-F) . This indicates that an androgen binding site is present on the plasma membranes in both follicle stages and that androgen binding is not to the AR.
Characterization of testosterone's effect on survival of G/T cells from early and late stage follicles
To determine the effect of testosterone on survival of G/T cells from early and late stage follicles, the incidence of apoptosis, as well as mRNA expression of the pro-apoptotic genes bax and p53, was examined. Testosterone significantly decreased the incidence of apoptosis compared to vehicle controls in early stage G/T cells but induced apoptosis in late stage G/T cells, as determined by TUNEL labeling (Figure 2A , representative images in Supplemental Figure S2A ). The incidence of apoptosis was also examined by Hoechst staining (Figure 2B , representative images in Supplemental Figure S2B ), which showed similar trends to that of the TUNEL assay, confirming the validity of the Hoechst assay for use in apoptosis analysis in subsequent experiments. Additionally, because the early stage follicle class contained both PNS and EV follicles, the effect of testosterone on apoptosis of G/T cells from the <100 μm (PNS) and 100-300 μm (EV) follicles was examined. Testosterone significantly decreased the incidence of apoptosis in G/T cells from both the <100 μm and 100-300 μm follicle pools (Supplemental Figure S1C) . Thus, it was determined that combining PNS and EV G/T cells was appropriate for examination of testosterone effects. The testosterone dose-response relationship and the androgen specificity of the anti-apoptotic response were examined in early stage G/T cells. The anti-apoptotic response showed an inverse dose-dependent relationship with 10 and 20 nM doses being more potent than 50 and 100 nM at inhibiting apoptosis ( Figure 2C ). The response was testosterone-dependent, with significantly reduced apoptosis in cells treated with free or BSA-conjugated testosterone (TBSA), but not with the nuclear AR agonist mibolerone ( Figure 2D ). The dose and specificity of the apoptotic response were not assessed in this study because these measures have previously been examined in croaker G/T cells that exhibit testosterone-induced apoptosis [15] . The mRNA expression of the pro-apoptotic members bax and p53 was differentially regulated by testosterone in G/T cells from early and late stage follicles, with late stage follicles showing a significant increase in expression and early stage showing significantly decreased expression of both bax and p53 mRNA ( Figure  2E-F) . To confirm that the addition of the aromatase inhibitor DLAminoglutethimide prevented any aromatization of testosterone to estradiol (E2), E2 was measured in the culture media after testosterone treatment of early and late stage G/T cells. E2 levels were not significantly increased in the media of testosterone-treated cells compared to vehicle-treated cells from either follicle stage (Supplemental Figure S3) . Therefore, the possibility of the observed effects being through estrogenic activity was ruled out.
Role of ZIP9 in the testosterone-mediated anti-apoptotic response
To determine which androgen receptor mediates the anti-apoptotic response of early stage G/T cells, the cells were transfected with siRNA targeting ZIP9 or the AR. The testosterone-mediated antiapoptotic response was lost after transfection with siRNA targeting ZIP9 but not with transfection of siRNA targeting AR ( Figure 3C -D). Western blot analysis of ZIP9 levels in plasma membrane samples verified they were significantly decreased in the siRNA treatment group, while the non-targeting control siRNA (Ctl) showed no decrease compared to the non-transfected control (NT) ( Figure 3A) . Quantitative PCR was used to examine expression of AR mRNA due to the unavailability of a commercial antibody that detects fish AR. A significant decrease in mRNA expression of AR after transfection with AR-targeting siRNA but not non-targeting siRNA was confirmed by qPCR ( Figure 3B ).
Testosterone modulation of intracellular free zinc and Gα signaling
Previous work has demonstrated that ZIP9 mediates testosteroneinduced apoptosis by increasing intracellular free zinc levels and by activating G s in croaker G/T cells from mature ovaries [14, 15] . Therefore, androgen regulation of intracellular zinc and members of the G s signaling pathway were examined in the ZIP9-mediated anti-apoptotic response. Testosterone and TBSA treatment significantly reduced intracellular free zinc levels of early stage G/T cells, while mibolerone had no effect ( Figure 4A ). ZIP9-targeting siRNA, but not AR-targeting, abrogated the effect of T on intracellular zinc levels ( Figure 4B ), indicating the decrease in free intracellular zinc is ZIP9-dependent. Treatment with the zinc chelator TPEN significantly reduced apoptosis compared to no treatment vehicle controls, similar to that of testosterone treatment ( Figure 4C ). In addition, the zinc ionophore Zn-pyrithione, which elevates intracellular zinc [40, 41] , antagonized the anti-apoptotic effect of testosterone ( Figure 4D ).Thus, low intracellular zinc levels both mimic and are essential for the testosterone-induced anti-apoptotic response. In early stage G/T cells the G s inhibitor NF449 had no effect on the testosteronemediated anti-apoptotic response ( Figure 4E ), indicating the response does not require G s activity. Co-treatment of testosterone with either the adenylyl cyclase activator forskolin or the cAMP analog 8-Bromoadenosine 3 ,5 -cyclic monophosphate (8-Br-cAMP) abolished the testosterone-mediated anti-apoptotic response ( Figure 4F ), indicating that G s -mediated signaling actively antagonizes the anti-apoptotic response. Early stage G/T cells treated with testosterone or TBSA showed a significant decrease in cAMP levels compared to vehicle, while mibolerone had no effect ( Figure 4G ). This effect on cAMP was blocked by ZIP9-targeting siRNA but not AR-targeting siRNA ( Figure 4H ), suggesting testosterone may lower cAMP levels by interaction with ZIP9 and activation of an inhibitory G protein in early stage G/T cells.
ZIP9-G protein interactions in early and late stage G/T cells
A PLA was used to examine if different G proteins may be able to interact with ZIP9 in G/T cells from early and late stage follicles.
ZIP9-G i and ZIP9-G s interactions (<40 nm) were evident in both G/T cell populations, but the intensity of the ZIP9-G i signal was enhanced in early follicle stage G/T cells while in late stage G/T cells (A) (B) (C) (D) (E) (F)
Figure 2. Effect of testosterone on apoptosis and expression of pro-apoptotic members in early and late stage G/T cells. A-B, Effect of testosterone on apoptosis of G/T cells from early and late stage follicles as determined by TUNEL staining (A) and Hoechst staining (B). C, Effect of various concentrations of testosterone on percentage apoptotic nuclei of G/T cells from early stage follicles. D, Effects of androgen treatments on percentage apoptotic nuclei of G/T cells from early stage follicles. E-F, Expression of bax (E) and p53 (F) mRNA after 24 h testosterone treatment of late and early stage G/T cells. All data represents means ± SEM, n = 6-9 (A-D), n = 12 (E, F). Significance was determined by one-(C-D) or two-way (A-B) ANOVA followed by Bonferroni multiple comparison post-test, or by Student's t-test (E-F)
. Different letters indicate significant differences between the treatment groups in the one-way ANOVA post hoc test at P < 0.05. Level of significance between vehicle and testosterone treatments as determined by Student's t-test or the two-way ANOVA post hoc are indicated as * , P < 0.05; * * , P < 0.01; * * * , P < 0.001. In experiments A-B, significant interactive effects of testosterone treatment on G/T cell survival between early and late stage cells was detected by the two-way ANOVA, which was predicted because early and late stage G/T cells show differential responses to testosterone. Incidence of apoptosis experiments (A-D) were repeated with three fish and each treatment conducted in duplicate or triplicate with similar results obtained for each. Pro-apoptotic member mRNA expression analyses (E-F) were repeated with six fish and each treatment conducted in duplicate. M, mibolerone; TBSA, testosterone-BSA.
the ZIP9-G s signal was more prevalent ( Figure 5A ). Additionally, in testosterone-treated late stage G/T cells that were TUNEL stained prior to PLA probing, apoptotic nuclei were found to co-localize with the ZIP9-G s interaction ( Figure 5B 
Discussion
This study demonstrates that the zinc transporter ZIP9 acts as a membrane androgen receptor to mediate differential survival responses in Atlantic croaker G/T cells in a follicle stage-dependent manner. While ZIP9 has previously been reported to elicit apoptosis of croaker G/T cells, here we demonstrate that this response can be attributed to G/T cells from late stage vitellogenic follicles. On the other hand, ZIP9 mediates an anti-apoptotic response in G/T cells from PNS and EV follicles. We have provided evidence that ZIP9 mediates these opposing responses by activating either a stimulatory or inhibitory G protein, dependent upon the stage of ovarian follicle development. Although it has been shown that ZIP9 can activate various G proteins in different models [14, 20, 21] , this is the first evidence indicating ZIP9 can activate multiple G proteins within a single cell model. Furthermore, the current work highlights that testosterone regulates opposite intracellular free zinc responses between early and late stage G/T cells, which corresponds to the opposite survival responses. The finding that ZIP9 can mediate both survival and apoptotic responses in croaker G/T cells depending on the stage of follicular development indicates that the receptor may play a critical role in multiple physiological processes essential for folliculogenesis and maintaining homeostasis in the ovary of Atlantic croaker. 5 μM) on testosterone inhibition of G/T cell apoptosis. E, Effect of Gs inhibitor NF449 (10 μM) on the anti-apoptotic effect of testosterone. F, Effects of 8-Br-cAMP (100 μM) and forskolin (10 μM) on the anti-apoptotic response to testosterone. G, Relative cAMP concentrations in early stage G/T cells treated with various androgens for 10 min. H, Effect of AR-and ZIP9-targeting siRNA on cAMP levels. All data represents means ± SEM, n = 3-4 (A, B), n = 6 (C-F), n = 6-9 (G, H). Significance was determined by one-(A, C, G) or two-way (B, D, E, F, H) ANOVA with Bonferroni multiple comparison post-test. Different letters indicate significant differences between the treatment groups in the one-way ANOVA post hoc test at P < 0.05. Level of significance between vehicle and testosterone treatments as determined by the two-way ANOVA post hoc are indicated as * , P < 0.05; * * , P < 0.01; * * * , P < 0.001. In experiments (B, H), significant interactive effects of the steroid treatment (V and T) and the transfection treatments on G/T cell zinc (B) and cAMP (H) levels were detected by two-way ANOVA, which was predicted because ZIP9-targeting siRNA blocked the testosterone-induced responses. In experiments (D, F), significant interactive effects of testosterone treatment in the presence of the pharmacological agents on G/T cell survival was detected by the two-way ANOVA, which was predicted and Gs antibodies or rabbit IgG control. C, E, Effect of Gi (NF 023, 10μM) and Gs (NF449, 10μM) inhibitors on testosterone-mediated survival and apoptosis, respectively. All data represents means ± SEM, n = 12-15 (A), n = 3 (B, D), n = 6 (C, E). Significance was determined by Student's t-test (A, B, D) or two-way ANOVA (C, E) with Bonferroni multiple comparison post-test. Level of significance between vehicle and testosterone treatments as determined by Student's t-test or two-way ANOVA post hoc are indicated as * , P < 0.05; * * , P < 0.01; * * * , P < 0.001. In experiments (C, E), significant interactive effects of testosterone treatment in the presence of the Gi and Gs inhibitors on G/T cell survival was detected by the two-way ANOVA, which .was predicted because the Gi inhibitor blocked testosterone-mediated anti-apoptosis, while the Gs inhibitor effectively blocked the apoptotic response. Experiments were repeated with 3-4 fish and with similar results obtained for each. NT, no treatment; Gi-Inhib, NF 023; Gs-Inhib, NF449.
Previously, a ZIP9-mediated apoptotic pathway was characterized using G/T cells pooled from the total follicles present in ovaries of reproductively mature fish (GSI > 12, average LV diameters >440 μm). This apoptotic pathway was found to involve the activation of a G s and upregulation of pro-apoptotic members [14, 15] , similar to that seen in late stage G/T cells in the current study. Thus, in G/T cells pooled from mature ovaries, the larger proportion of late stage G/T cells mask any differential phenotypes of the early stage G/T cells. Similarly, in the early stage G/T cells assessed in the current study, contamination of LV follicle G/T cells does not appear to affect the testosterone response, since G/T cells from the early stage class (Figure 1 ) which contain LV contamination exhibit the same anti-apoptotic response as G/T cells from only PNS and EV follicles (Supplemental Figure S1A-C) . Therefore, in the current study cross contamination of early and late stage G/T cells was not a major concern since the respective anti-and pro-apoptotic responses were regularly observed.
Arguably the most important finding of this study is that ZIP9-mediates testosterone-induced pro-and anti-apoptotic responses through activation of different G proteins and subsequent different signaling cascades. Previously, the ZIP9-mediated apoptotic pathway was characterized as involving G s -mediated signaling, MAPkinase activity, and a rise in intracellular free zinc [14, 15] . These signaling events are upstream of increases in caspase 3 activity, increased mRNA expression of pro-apoptotic members, and cell death by apoptosis. In the current study, the antiapoptotic response is characterized by G i activation, subsequent decreased cAMP levels, and decreased mRNA expression of proapoptotic members and apoptosis. Furthermore, the anti-apoptotic response downstream of G i -mediated signaling is antagonized by G s -mediated signaling as demonstrated by the inhibitory effect of an adenylyl cyclase activator or cAMP analog on the anti-apoptotic response.
In croaker G/T cells, mPRα also mediates an anti-apoptotic response through activation of a G i [33] and corresponding PI3K/Akt and MAPkinase signaling. Of interest, preliminary data (Supplemental Figure S4 ) indicate that Wortmannin, a PI3K inhibitor, blocks the testosterone-mediated anti-apoptotic response in early stage G/T cells, which suggests PI3K/Akt signaling may be involved in this testosterone-mediated response. In addition, MAPkinase has been shown to play a role in extranuclear AR signaling in murine granulosa cells [42] . The AR plays a protective role in murine pre-antral granulosa cells through both extranuclear and nuclear androgen signaling [6, 42] . Thus, it is of interest to investigate the involvement of additional signaling members in the ZIP9-mediated anti-apoptotic response in croaker ovarian follicles and the potential shared protective mechanisms between the AR and ZIP9.
Interestingly, it was found that the effect of testosterone on intracellular free zinc levels also differs between early and late stage G/T cells. While the ZIP9-mediated apoptotic pathway involves an increase in free intracellular zinc [14] , an opposite trend in the present study was found in early stage G/T cells that exhibit the anti-apoptotic response. Previously, the rise in intracellular free zinc associated with androgen-induced apoptosis in croaker G/T cells was attributed to ZIP9 activity and found to be essential for the induction of androgen-induced apoptosis [14] . In human breast and prostate cancer cell lines, ZIP9-mediated apoptosis also requires a ZIP9-dependent increase in intracellular free zinc, which is downstream of G i activation [25] . To our knowledge, ZIP9 is the only ZIP family member that regulates zinc by G protein activation, but its ability to do so has not been examined in the croaker G/T cell model. It is of interest to further examine the testosterone-induced decrease in free intracellular zinc exhibited by early stage G/T cells and the role of ZIP9. ZIP family members regulate the transport of zinc into the cytoplasmic compartment [43] . Thus, the observed decrease in free zinc may be mediated by an androgen-dependent inhibition of the zinc transport activity of ZIP9, resulting in reduced zinc transport into the cytoplasm from extracellular and subcellular compartments. However, further work is required to verify the mechanism of action of this response.
While ZIP9 can activate different G proteins in croaker G/T cells, a G i in early stage follicles followed by G s in late stage follicles, the mechanism driving the switch in activation is unclear. Whereas most GPCRs are associated with a single class of G proteins, a number of receptors are known to have the ability to couple to different classes of G proteins within a single model. This was first documented for the β 2 -adrenergic receptor (β 2 -AR) [44] but has further been established for other GPCRs including the β 1 -adrenergic, the prostacyclin, and vasoactive intestinal peptide receptors [45] [46] [47] . Similar to the current study, the β 2 -AR can mediate both pro-and anti-apoptotic responses through activation of a G s and G i , respectively, in cardiac myocytes [48] . While the current study does not address the mechanism behind this shift in ZIP9-G protein coupling, the fact that ZIP9 can couple to multiple G proteins in the current model as well as different G proteins between models indicate that ZIP9-G protein interactions should be further examined to determine if ZIP9 can activate multiple G proteins in other models.
Androgens have been found to promote survival and growth as well as cell death in various mammalian and fish ovarian models [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . In mammals, these different responses to androgens are likely follicle stage-dependent [49, 50] , and can be mediated through both direct and indirect mechanisms. In early stage mammalian ovarian follicles, androgens act directly on ovarian follicles to promote growth [1, 2] , proliferation [1, 6] , and inhibit apoptosis [1, 6] , but also promote follicle-stimulating hormone (FSH) stimulation of aromatase activity to increase estrogen production [2, 51] . In later stages of follicle development, androgens promote apoptosis and atresia [4-8, 52, 53] , and reduce FSH-induced aromatase activity. The current study indicates that in Atlantic croaker ovaries, androgens act to directly promote survival of G/T cells from early stage follicles as well as induce apoptosis of cells from late stage follicles, similarly to that seen in mammals. While androgen-induced survival and growth of early stage teleost follicles has previously been reported [13] , the role of androgens in ovarian apoptotic events has not been examined in other teleost models. Therefore, the physiological significance of androgen-induced apoptosis in late stage croaker ovarian follicles is currently unknown. In teleosts, apoptosis occurs during atresia, similar to that observed in mammals, and is also involved in postovulatory follicle breakdown [54] [55] [56] [57] . Thus, ZIP9 may play a role in induction of apoptosis during atresia or postovulatory breakdown in vivo, however, further investigation into the receptor's role in these processes is required.
The ovaries of mammalian and asynchronous spawning teleosts consist of heterogeneous follicle populations. Thus, folliculogenesis requires precise control at the level of an individual follicle to allow for development independent of other follicles present in the ovary. Folliculogenesis of individual follicles is likely mediated by multiple levels of control. This may include the milieu of the intrafollicle microenvironment, in which follicle-derived factors can act in both paracrine and autocrine fashions. In addition, the regulation of the expression of receptors can be used to control the sensitivity of the follicle to different stimuli. The ability of ZIP9 to differentially regulate survival and apoptosis depending of follicular stage is likely another means of control of folliculogenesis at the level of individual follicles. Androgens are present in serum and ovarian plasma throughout the reproductive season in teleosts [58] , thus, ZIP9 may allow androgens to act through a single receptor to elicit different responses in a follicle stage-dependent manner.
In conclusion, the present study demonstrates that in Atlantic croaker G/T cells the novel membrane androgen receptor ZIP9 shows follicle stage-dependent G protein interactions. In early stage G/T cells, testosterone interacts with ZIP9 to activate a G i and corresponding reductions in intracellular free zinc, cAMP, and incidence couples to an inhibitory G protein which leads to decreased cAMP and intracellular free zinc levels, with downstream decreases in pro-apoptotic member mRNA expression and reduced apoptosis incidence. In late stage G/T cells, ZIP9 couples to a stimulatory G protein which increases cAMP and intracellular free zinc levels, and corresponds to activation of PKA, increased expression of pro-apoptotic member mRNA, and higher incidence of apoptosis. T, testosterone; Gi, inhibitory G protein; Gs, Stimulatory G protein; PKA, protein kinase A.
of apoptosis are observed. In late stage G/T cells, testosterone treatment results in ZIP9 activation of a G s and corresponding increases in intracellular free zinc, cAMP, and apoptosis incidence. A proposed model summarizing these ZIP9-mediated responses is presented in Figure 7 . This is the first evidence that ZIP9 can mediate different physiological responses by activating multiple G proteins in a single model, and provides a model for androgen regulation of opposite survival responses in ovarian follicle cells, a process that has been observed in both mammals and teleosts. Although the physiological relevance of the pro-and anti-apoptotic responses was not investigated in the current study, the ability of a single receptor to elicit opposing responses at different developmental stages may be a mechanism that allows for more precise control of folliculogenesis in the dynamic ovarian environment. ZIP9 is expressed in the majority of croaker and human tissues examined, but knowledge on ZIP9's role in meditation of androgen-induced responses in vertebrates is greatly lacking. Additional studies on the role of ZIP9 in the ovary of teleosts as well as higher vertebrates will provide insight into the role of the receptor in ovarian physiology. Our current findings indicate that ZIP9 possesses unique characteristics that warrant further investigation in a wide range of vertebrate models.
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Supplementary data are available at BIOLRE online. Figure 1 . Characterization and comparison of <100 μm and 100-300 μm follicle size classes. A, Relative composition of <100 μm and 100-300 μm follicle size classes. B, Average follicle diameter (± SD) of follicles in the <100 μm and 100-300 μm follicle size classes. C, Effect of testosterone on apoptosis incidence of G/T cells from <100 μm and 100-300 μm follicle size classes.
Supplemental
Data represents means ± SEM (C), n = 3 (A, B), n = 6 (C). Significance was determined by Student's t-test. * * * , P < 0.001. Experiments were repeated with three fish. For experiment C, each treatment was conducted in duplicate with similar results obtained for each. Supplemental Figure 2 . Representative images of TUNEL and Hoechst apoptosis analyses for early and late stage croaker G/T cells (corresponding bar graphs depicted in Figure 2A and B). Supplemental Figure 3 . Estradiol content of cell culture media. Early and late stage G/T cells showed similar trends so data was combined. Data represents means ± SEM n = 12. Significance was determined by one-way ANOVA followed by Bonferroni multiple comparison post-test. Different letters indicate significant differences between the treatment groups in the post hoc test at P < 0.05. The experiment was repeated with early and late stage G/T cells from three fish, with treatments conducted in duplicate. Supplemental Figure 4 , Effect of PI3K inhibitor Wortmannin (10 nM) on the anti-apoptotic effect of testosterone in early stage croaker G/T cells. Data represents means ± SEM, n = 6. Significance was determined by two-way ANOVA with Bonferroni multiple comparison post-test. Level of significance between vehicle and testosterone treatments as determined by the post hoc is indicated as * * * , P < 0.001. Significant interactive effects of testosterone treatment in the presence of Wortmannin on G/T cell survival was detected by the two-way ANOVA, which was predicted because Wortmannin effectively blocked the testosterone-mediated response. The experiment was repeated using three fish, with treatments conducted in duplicate. NT, no treatment. Supplemental Table 1 . Sequence of primers (5 -3 ) used for qPCR experiments. Supplemental Table 2 . List of antibodies used in this study.
